Lara Quinten , Giancarlo Natalucci , Mark Adams , Cristina Borradori-Tolsa , Myriam Bickle-Graz , Sebastian Grunt , the Swiss Neonatal Network and Follow-up Group
{"title":"Incidence, subtypes and severity of cerebral palsy in infants born extremely preterm in Switzerland: A retrospective study comparing two time periods","authors":"Lara Quinten , Giancarlo Natalucci , Mark Adams , Cristina Borradori-Tolsa , Myriam Bickle-Graz , Sebastian Grunt , the Swiss Neonatal Network and Follow-up Group","doi":"10.1016/j.earlhumdev.2025.106328","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>In 2011, the Swiss Society of Neonatology issued new guidelines for the care of preterm infants at the limit of viability leading to higher survival of infants born <28 weeks of gestation. It is unclear whether and how these recommendations affected the prevalence and severity of cerebral palsy (CP).</div></div><div><h3>Objective</h3><div>To investigate whether the prevalence, severity, and subtypes of CP in extremely preterm infants differ in two successive birth cohorts.</div></div><div><h3>Methods</h3><div>Retrospective, population-based analysis of prospectively collected data on infants born <28 weeks of gestation. CP prevalence, subtypes (Surveillance of cerebral palsy in Europe – SCPE classification), and severity (Gross Motor Function Classification System - GMFCS) assessed at 2 years corrected were compared between the two birth cohorts (2006–2011 and 2012–2017).</div></div><div><h3>Results</h3><div>Of 3244 registered infants, 2090 survived, of whom 1764 were followed up (84 %). Mortality was 38 % for the first period and 33 % for the second (<em>p</em> = 0.003) and 112 were diagnosed with CP. CP prevalence was 34.5 per 1000 live births (37.0 for 2006–2011 and 32.4 for birth-years 2012–2017, <em>p</em> = 0.476). A trend towards more bilateral spastic CP (2006–2011: 32 % and 2012–2017: 50 %, <em>p</em> = 0.055) and more severe cases (2006–2011: 14.3 % and 2012–2017: 24.9 %, <em>p</em> = 0.154) was observed in the second period. CP severity was associated with cystic periventricular leukomalacia (PVL) (OR 3.4, 95 %-CI 1.1–10.3, <em>p</em> = 0.033) and necrotizing enterocolitis (NEC) (OR 5.5, 95 % CI 1.2–25.1, <em>p</em> = 0.028) but not with other neonatal morbidities.</div></div><div><h3>Conclusion</h3><div>These results suggest that the greater number of bilateral forms and severe cases of CP could be due to the higher number of surviving infants in the 2011–2017 cohort. PVL and NEC are the factors mostly associated with severe cases of CP in Switzerland.</div></div>","PeriodicalId":11435,"journal":{"name":"Early human development","volume":"209 ","pages":"Article 106328"},"PeriodicalIF":2.2000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Early human development","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378378225001380","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
In 2011, the Swiss Society of Neonatology issued new guidelines for the care of preterm infants at the limit of viability leading to higher survival of infants born <28 weeks of gestation. It is unclear whether and how these recommendations affected the prevalence and severity of cerebral palsy (CP).
Objective
To investigate whether the prevalence, severity, and subtypes of CP in extremely preterm infants differ in two successive birth cohorts.
Methods
Retrospective, population-based analysis of prospectively collected data on infants born <28 weeks of gestation. CP prevalence, subtypes (Surveillance of cerebral palsy in Europe – SCPE classification), and severity (Gross Motor Function Classification System - GMFCS) assessed at 2 years corrected were compared between the two birth cohorts (2006–2011 and 2012–2017).
Results
Of 3244 registered infants, 2090 survived, of whom 1764 were followed up (84 %). Mortality was 38 % for the first period and 33 % for the second (p = 0.003) and 112 were diagnosed with CP. CP prevalence was 34.5 per 1000 live births (37.0 for 2006–2011 and 32.4 for birth-years 2012–2017, p = 0.476). A trend towards more bilateral spastic CP (2006–2011: 32 % and 2012–2017: 50 %, p = 0.055) and more severe cases (2006–2011: 14.3 % and 2012–2017: 24.9 %, p = 0.154) was observed in the second period. CP severity was associated with cystic periventricular leukomalacia (PVL) (OR 3.4, 95 %-CI 1.1–10.3, p = 0.033) and necrotizing enterocolitis (NEC) (OR 5.5, 95 % CI 1.2–25.1, p = 0.028) but not with other neonatal morbidities.
Conclusion
These results suggest that the greater number of bilateral forms and severe cases of CP could be due to the higher number of surviving infants in the 2011–2017 cohort. PVL and NEC are the factors mostly associated with severe cases of CP in Switzerland.
期刊介绍:
Established as an authoritative, highly cited voice on early human development, Early Human Development provides a unique opportunity for researchers and clinicians to bridge the communication gap between disciplines. Creating a forum for the productive exchange of ideas concerning early human growth and development, the journal publishes original research and clinical papers with particular emphasis on the continuum between fetal life and the perinatal period; aspects of postnatal growth influenced by early events; and the safeguarding of the quality of human survival.
The first comprehensive and interdisciplinary journal in this area of growing importance, Early Human Development offers pertinent contributions to the following subject areas:
Fetology; perinatology; pediatrics; growth and development; obstetrics; reproduction and fertility; epidemiology; behavioural sciences; nutrition and metabolism; teratology; neurology; brain biology; developmental psychology and screening.